
<!DOCTYPE html>
<html>
<meta charset="UTF-8">
<head>
  <title>Topic 11 -- Abstracts with Biological Entities (English) - 75 Topics / Sub-Topic Model 15 - 15 Topics</title>

<style>
table {
  font-family: "Trebuchet MS", Arial, Helvetica, sans-serif;
  border-collapse: collapse;
  width: 100%;
}

td, th {
  border: 1px solid #ddd;
  padding: 8px;
}

tr:nth-child(even){background-color: #f2f2f2;}

tr:hover {background-color: #ddd;}

th {
  padding-top: 12px;
  padding-bottom: 12px;
  text-align: left;
  background-color: #0099FF;
  color: white;
}
</style>

</head>
<body>
<h2>Topic 11 -- Abstracts with Biological Entities (English) - 75 Topics / Sub-Topic Model 15 - 15 Topics</h2>
<table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th></th>
      <th>cite ad</th>
      <th>title</th>
      <th>authors</th>
      <th>publish year</th>
      <th>publish time</th>
      <th>dataset</th>
      <th>abstract mentions covid</th>
      <th>pmcid</th>
      <th>pubmed id</th>
      <th>doi</th>
      <th>cord uid</th>
      <th>topic weight</th>
      <th>Similarity scispacy</th>
      <th>Similarity specter</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <th id="v9s8xynb";>1</th>
      <td>De_Clercq_2007</td>
      <td>Status presens of antiviral drugs and strategies: Part II: RNA VIRUSES (EXCEPT RETROVIRUSES)</td>
      <td>De Clercq, Erik</td>
      <td>2007</td>
      <td>2007-12-31</td>
      <td>PMC</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7146830" target="_blank">PMC7146830</a></td>
      <td></td>
      <td><a href="https://doi.org/10.1016/s1075-8593(06)05002-7" target="_blank">10.1016/s1075-8593(06)05002-7</a></td>
      <td>v9s8xynb</td>
      <td>0.888706</td>
      <td><a href="Topic_11.html#hwpu6mko">De_Clercq_2007</a></td>
      <td><a href="Topic_11.html#7ujqdujd">De_Clercq_2007</a>, <a href="Topic_02.html#1vxl2468">Debing_2013</a>, <a href="Topic_02.html#8jin6oru">Martínez_2008</a>, <a href="Topic_11.html#hwpu6mko">De_Clercq_2007</a></td>
    </tr>
    <tr>
      <th id="7ujqdujd";>2</th>
      <td>De_Clercq_2007</td>
      <td>Status Presens of Antiviral Drugs And Strategies: Part I: DNA Viruses and Retroviruses</td>
      <td>De Clercq, Erik</td>
      <td>2007</td>
      <td>2007-12-31</td>
      <td>PMC</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7146823" target="_blank">PMC7146823</a></td>
      <td></td>
      <td><a href="https://doi.org/10.1016/s1075-8593(06)05001-5" target="_blank">10.1016/s1075-8593(06)05001-5</a></td>
      <td>7ujqdujd</td>
      <td>0.872262</td>
      <td><a href="Topic_11.html#hwpu6mko">De_Clercq_2007</a></td>
      <td><a href="Topic_11.html#v9s8xynb">De_Clercq_2007</a>, <a href="Topic_11.html#hwpu6mko">De_Clercq_2007</a>, <a href="Topic_02.html#1vxl2468">Debing_2013</a>, <a href="Topic_02.html#8jin6oru">Martínez_2008</a></td>
    </tr>
    <tr>
      <th id="hwpu6mko";>3</th>
      <td>De_Clercq_2007</td>
      <td>7.10 Viruses and Viral Diseases</td>
      <td>De Clercq, E.</td>
      <td>2007</td>
      <td>2007-12-31</td>
      <td>PMC</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7151824" target="_blank">PMC7151824</a></td>
      <td></td>
      <td><a href="https://doi.org/10.1016/b0-08-045044-x/00211-x" target="_blank">10.1016/b0-08-045044-x/00211-x</a></td>
      <td>hwpu6mko</td>
      <td>0.790501</td>
      <td></td>
      <td><a href="Topic_02.html#itz0bdrc">Paintsil_2009</a>, <a href="Topic_02.html#ng6h4l3m">Vardanyan_2016</a></td>
    </tr>
    <tr>
      <th id="53xret5p";>4</th>
      <td>Clercq_2012</td>
      <td>Highlights in Antiviral Drug Research: Antivirals at the Horizon</td>
      <td>Clercq, Erik De</td>
      <td>2012</td>
      <td>2012-05-02</td>
      <td>PMC</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7168470" target="_blank">PMC7168470</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/22553111.0" target="_blank">22553111.0</a></td>
      <td><a href="https://doi.org/10.1002/med.21256" target="_blank">10.1002/med.21256</a></td>
      <td>53xret5p</td>
      <td>0.672173</td>
      <td><a href="Topic_11.html#hwpu6mko">De_Clercq_2007</a></td>
      <td></td>
    </tr>
    <tr>
      <th id="rmxin1da";>5</th>
      <td>De_Clercq_2019</td>
      <td>New Nucleoside Analogues for the Treatment of Hemorrhagic Fever Virus Infections</td>
      <td>De Clercq, Erik</td>
      <td>2019</td>
      <td>2019-08-07</td>
      <td>PMC</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7159701" target="_blank">PMC7159701</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/31389664.0" target="_blank">31389664.0</a></td>
      <td><a href="https://doi.org/10.1002/asia.201900841" target="_blank">10.1002/asia.201900841</a></td>
      <td>rmxin1da</td>
      <td>0.650228</td>
      <td></td>
      <td></td>
    </tr>
    <tr>
      <th id="dkt4cqer";>6</th>
      <td>De_Clercq_2010</td>
      <td>The next ten stories on antiviral drug discovery (part E): advents, advances, and adventures</td>
      <td>De Clercq, Erik</td>
      <td>2010</td>
      <td>2010-12-13</td>
      <td>PMC</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7168424" target="_blank">PMC7168424</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/19844936.0" target="_blank">19844936.0</a></td>
      <td><a href="https://doi.org/10.1002/med.20179" target="_blank">10.1002/med.20179</a></td>
      <td>dkt4cqer</td>
      <td>0.606955</td>
      <td></td>
      <td></td>
    </tr>
    <tr>
      <th id="4t2y69o9";>7</th>
      <td>Kim_Y_2016</td>
      <td>Potent inhibition of enterovirus D68 and human rhinoviruses by dipeptidyl aldehydes and α-ketoamides</td>
      <td>Kim, Yunjeong; Kankanamalage, Anushka C. Galasiti; Damalanka, Vishnu C.; Weerawarna, Pathum M.; Groutas, William C.; Chang, Kyeong-Ok</td>
      <td>2016</td>
      <td>2016-01-31</td>
      <td>None</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4698184" target="_blank">PMC4698184</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/26658373.0" target="_blank">26658373.0</a></td>
      <td><a href="https://doi.org/10.1016/j.antiviral.2015.11.010" target="_blank">10.1016/j.antiviral.2015.11.010</a></td>
      <td>4t2y69o9</td>
      <td>0.496260</td>
      <td></td>
      <td><a href="Topic_03.html#wgzpd6te">Wu_H_2016</a></td>
    </tr>
    <tr>
      <th id="jnketv7y";>8</th>
      <td>Cheng_2016</td>
      <td>Enfuvirtide−PEG conjugate: A potent HIV fusion inhibitor with improved pharmacokinetic properties</td>
      <td>Cheng, Shuihong; Wang, Yan; Zhang, Zhenxing; Lv, Xun; Gao, George F.; Shao, Yiming; Ma, Liying; Li, Xuebing</td>
      <td>2016</td>
      <td>2016-10-04</td>
      <td>PMC</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115413" target="_blank">PMC7115413</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/27240277.0" target="_blank">27240277.0</a></td>
      <td><a href="https://doi.org/10.1016/j.ejmech.2016.05.027" target="_blank">10.1016/j.ejmech.2016.05.027</a></td>
      <td>jnketv7y</td>
      <td>0.489259</td>
      <td></td>
      <td><a href="Topic_08.html#qhhdjgeq">Zhu_X_2015</a></td>
    </tr>
    <tr>
      <th id="t8jzsrb7";>9</th>
      <td>Jefferson_2009</td>
      <td>Antivirals for the common cold</td>
      <td>Jefferson, Tom</td>
      <td>2009</td>
      <td>2009-11-10</td>
      <td>PMC</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7123222" target="_blank">PMC7123222</a></td>
      <td></td>
      <td><a href="https://doi.org/10.1007/978-3-7643-9912-2_10" target="_blank">10.1007/978-3-7643-9912-2_10</a></td>
      <td>t8jzsrb7</td>
      <td>0.486216</td>
      <td></td>
      <td><a href="Topic_01.html#4h73lukj">Peyclit_2019</a>, <a href="Topic_03.html#wgzpd6te">Wu_H_2016</a></td>
    </tr>
    <tr>
      <th id="i94lyfsh";>10</th>
      <td>Ellner_1988</td>
      <td>Management of acute and chronic respiratory tract infections</td>
      <td>Ellner, Jerrold J.</td>
      <td>1988</td>
      <td>1988-09-16</td>
      <td>PMC</td>
      <td>N</td>
      <td></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/3048091.0" target="_blank">3048091.0</a></td>
      <td><a href="https://doi.org/10.1016/0002-9343(88)90456-1" target="_blank">10.1016/0002-9343(88)90456-1</a></td>
      <td>i94lyfsh</td>
      <td>0.482694</td>
      <td><a href="Topic_02.html#ali14j7x">Wisskirchen_2014</a></td>
      <td></td>
    </tr>
    <tr>
      <th id="hr46kv03";>11</th>
      <td>Baltina_2010</td>
      <td>Prospects for the creation of new antiviral drugs based on glycyrrhizic acid and its derivatives (a review)</td>
      <td>Baltina, L. A.; Kondratenko, R. M.; Baltina, L. A.; Plyasunova, O. A.; Pokrovskii, A. G.; Tolstikov, G. A.</td>
      <td>2010</td>
      <td>2010-02-04</td>
      <td>PMC</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7089237" target="_blank">PMC7089237</a></td>
      <td></td>
      <td><a href="https://doi.org/10.1007/s11094-010-0348-2" target="_blank">10.1007/s11094-010-0348-2</a></td>
      <td>hr46kv03</td>
      <td>0.458397</td>
      <td></td>
      <td><a href="Topic_06.html#vuj5kjl5">Liu_A_2012</a>, <a href="Topic_02.html#e4kd2jgy">Bekut_2018</a>, <a href="Topic_02.html#gxbrgy6g">Lee_C_2019</a></td>
    </tr>
    <tr>
      <th id="hkxlq3os";>12</th>
      <td>Anang_2018</td>
      <td>Recent Advances Towards the Development of a Potent Antiviral Against the Hepatitis E Virus</td>
      <td>Anang, Saumya; Kaushik, Nidhi; Surjit, Milan</td>
      <td>2018</td>
      <td>2018-06-28</td>
      <td>NONCOMM</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6160310" target="_blank">PMC6160310</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/30271744.0" target="_blank">30271744.0</a></td>
      <td><a href="https://doi.org/10.14218/jcth.2018.00005" target="_blank">10.14218/jcth.2018.00005</a></td>
      <td>hkxlq3os</td>
      <td>0.431123</td>
      <td></td>
      <td><a href="Topic_02.html#k4tghibp">D’Alessandro_2020</a>, <a href="Topic_11.html#n0acj460">Debing_2014</a></td>
    </tr>
    <tr>
      <th id="qovrstak";>13</th>
      <td>Deval_2014</td>
      <td>Inhibition of viral RNA polymerases by nucleoside and nucleotide analogs: therapeutic applications against positive-strand RNA viruses beyond hepatitis C virus</td>
      <td>Deval, Jerome; Symons, Julian A; Beigelman, Leo</td>
      <td>2014</td>
      <td>2014-12-31</td>
      <td>PMC</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7102778" target="_blank">PMC7102778</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/25194816.0" target="_blank">25194816.0</a></td>
      <td><a href="https://doi.org/10.1016/j.coviro.2014.08.004" target="_blank">10.1016/j.coviro.2014.08.004</a></td>
      <td>qovrstak</td>
      <td>0.422351</td>
      <td></td>
      <td><a href="Topic_02.html#ng6h4l3m">Vardanyan_2016</a></td>
    </tr>
    <tr>
      <th id="hpuogyb0";>14</th>
      <td>Razonable_2011</td>
      <td>Antiviral Drugs for Viruses Other Than Human Immunodeficiency Virus</td>
      <td>Razonable, Raymund R.</td>
      <td>2011</td>
      <td>2011-10-31</td>
      <td>None</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3184032" target="_blank">PMC3184032</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/21964179.0" target="_blank">21964179.0</a></td>
      <td><a href="https://doi.org/10.4065/mcp.2011.0309" target="_blank">10.4065/mcp.2011.0309</a></td>
      <td>hpuogyb0</td>
      <td>0.420112</td>
      <td></td>
      <td><a href="Topic_02.html#ng6h4l3m">Vardanyan_2016</a>, <a href="Topic_02.html#itz0bdrc">Paintsil_2009</a>, <a href="Topic_02.html#d4qcckh1">Meanwell_2003</a></td>
    </tr>
    <tr>
      <th id="5rsk6g7l";>15</th>
      <td>Kinast_2019</td>
      <td>Hepatitis E Virus Drug Development</td>
      <td>Kinast, Volker; Burkard, Thomas L; Todt, Daniel; Steinmann, Eike</td>
      <td>2019</td>
      <td>2019-05-28</td>
      <td>COMM-USE</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6631701" target="_blank">PMC6631701</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/31141919.0" target="_blank">31141919.0</a></td>
      <td><a href="https://doi.org/10.3390/v11060485" target="_blank">10.3390/v11060485</a></td>
      <td>5rsk6g7l</td>
      <td>0.401327</td>
      <td><a href="Topic_02.html#t2vdzppd">Jerome_2005</a></td>
      <td><a href="Topic_11.html#n0acj460">Debing_2014</a></td>
    </tr>
    <tr>
      <th id="hb1inqy8";>16</th>
      <td>Schandock_2017</td>
      <td>Macromolecular Antiviral Agents against Zika, Ebola, SARS, and Other Pathogenic Viruses</td>
      <td>Schandock, Franziska; Riber, Camilla Frich; Röcker, Annika; Müller, Janis A.; Harms, Mirja; Gajda, Paulina; Zuwala, Kaja; Andersen, Anna H. F.; Løvschall, Kaja Borup; Tolstrup, Martin; Kreppel, Florian; Münch, Jan; Zelikin, Alexander N.</td>
      <td>2017</td>
      <td>2017-09-25</td>
      <td>PMC</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7161897" target="_blank">PMC7161897</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/28945945.0" target="_blank">28945945.0</a></td>
      <td><a href="https://doi.org/10.1002/adhm.201700748" target="_blank">10.1002/adhm.201700748</a></td>
      <td>hb1inqy8</td>
      <td>0.401257</td>
      <td></td>
      <td></td>
    </tr>
    <tr>
      <th id="uajl5wyk";>17</th>
      <td>Feng_2018</td>
      <td>Addressing the selectivity and toxicity of antiviral nucleosides</td>
      <td>Feng, Joy Y</td>
      <td>2018</td>
      <td>2018-03-13</td>
      <td>NONCOMM</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5890540" target="_blank">PMC5890540</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/29534607.0" target="_blank">29534607.0</a></td>
      <td><a href="https://doi.org/10.1177/2040206618758524" target="_blank">10.1177/2040206618758524</a></td>
      <td>uajl5wyk</td>
      <td>0.395733</td>
      <td><a href="Topic_02.html#t2vdzppd">Jerome_2005</a></td>
      <td><a href="Topic_02.html#8jin6oru">Martínez_2008</a>, <a href="Topic_08.html#qhhdjgeq">Zhu_X_2015</a>, <a href="Topic_03.html#201jppkd">Al‐Bari_2017</a></td>
    </tr>
    <tr>
      <th id="5rpdt3fs";>18</th>
      <td>Berdis_2008</td>
      <td>DNA Polymerases as Therapeutic Targets</td>
      <td>Berdis, Anthony J.</td>
      <td>2008</td>
      <td>2008-08-01</td>
      <td>PMC</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2692436" target="_blank">PMC2692436</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/18642851.0" target="_blank">18642851.0</a></td>
      <td><a href="https://doi.org/10.1021/bi801179f" target="_blank">10.1021/bi801179f</a></td>
      <td>5rpdt3fs</td>
      <td>0.339156</td>
      <td></td>
      <td></td>
    </tr>
    <tr>
      <th id="d9borky8";>19</th>
      <td>Blaising_2014</td>
      <td>Arbidol as a broad-spectrum antiviral: An update</td>
      <td>Blaising, Julie; Polyak, Stephen J.; Pécheur, Eve-Isabelle</td>
      <td>2014</td>
      <td>2014-07-31</td>
      <td>PMC</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7113885" target="_blank">PMC7113885</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/24769245.0" target="_blank">24769245.0</a></td>
      <td><a href="https://doi.org/10.1016/j.antiviral.2014.04.006" target="_blank">10.1016/j.antiviral.2014.04.006</a></td>
      <td>d9borky8</td>
      <td>0.337571</td>
      <td><a href="Topic_02.html#t2vdzppd">Jerome_2005</a></td>
      <td><a href="Topic_02.html#gxbrgy6g">Lee_C_2019</a></td>
    </tr>
    <tr>
      <th id="2h6es4x4";>20</th>
      <td>Sperber_1987</td>
      <td>Antiviral Chemotherapyand Prophylaxis of Viral Respiratory Disease</td>
      <td>Sperber, Steven J.; Hayden, Frederick G.</td>
      <td>1987</td>
      <td>1987-12-31</td>
      <td>PMC</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7131954" target="_blank">PMC7131954</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/2446820.0" target="_blank">2446820.0</a></td>
      <td><a href="https://doi.org/10.1016/s0272-2712(18)30721-2" target="_blank">10.1016/s0272-2712(18)30721-2</a></td>
      <td>2h6es4x4</td>
      <td>0.328038</td>
      <td></td>
      <td><a href="Topic_02.html#k4tghibp">D’Alessandro_2020</a></td>
    </tr>
    <tr>
      <th id="vasphfdy";>21</th>
      <td>Ramírez-Olivencia_2019</td>
      <td>Use of ribavirin in viruses other than hepatitis C. A review of the evidence</td>
      <td>Ramírez-Olivencia, German; Estébanez, Miriam; Membrillo, Francisco Javier; Ybarra, Maria del Carmen</td>
      <td>2019</td>
      <td>2019-11-30</td>
      <td>PMC</td>
      <td>N</td>
      <td></td>
      <td></td>
      <td><a href="https://doi.org/10.1016/j.eimce.2018.05.018" target="_blank">10.1016/j.eimce.2018.05.018</a></td>
      <td>vasphfdy</td>
      <td>0.327639</td>
      <td><a href="Topic_02.html#t2vdzppd">Jerome_2005</a></td>
      <td><a href="Topic_02.html#k4tghibp">D’Alessandro_2020</a></td>
    </tr>
    <tr>
      <th id="n0acj460";>22</th>
      <td>Debing_2014</td>
      <td>Antiviral strategies for hepatitis E virus</td>
      <td>Debing, Yannick; Neyts, Johan</td>
      <td>2014</td>
      <td>2014-02-28</td>
      <td>PMC</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7113752" target="_blank">PMC7113752</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/24374149.0" target="_blank">24374149.0</a></td>
      <td><a href="https://doi.org/10.1016/j.antiviral.2013.12.005" target="_blank">10.1016/j.antiviral.2013.12.005</a></td>
      <td>n0acj460</td>
      <td>0.327028</td>
      <td><a href="Topic_02.html#t2vdzppd">Jerome_2005</a>, <a href="Topic_02.html#ali14j7x">Wisskirchen_2014</a></td>
      <td></td>
    </tr>
    <tr>
      <th id="d4qcckh1";>23</th>
      <td>Meanwell_2003</td>
      <td>Chapter 22. Non-HIV antiviral agents</td>
      <td>Meanwell, Nicholas A.; Serrano-Wu, Michael H.; Snyder, Lawrence B.</td>
      <td>2003</td>
      <td>2003-12-31</td>
      <td>PMC</td>
      <td>N</td>
      <td></td>
      <td></td>
      <td><a href="https://doi.org/10.1016/s0065-7743(03)38023-6" target="_blank">10.1016/s0065-7743(03)38023-6</a></td>
      <td>d4qcckh1</td>
      <td>0.306118</td>
      <td></td>
      <td><a href="Topic_02.html#ng6h4l3m">Vardanyan_2016</a>, <a href="Topic_02.html#itz0bdrc">Paintsil_2009</a></td>
    </tr>
    <tr>
      <th id="ycc3csyh";>24</th>
      <td>Rollinger_2010</td>
      <td>The human rhinovirus: human‐pathological impact, mechanisms of antirhinoviral agents, and strategies for their discovery</td>
      <td>Rollinger, Judith M.; Schmidtke, Michaela</td>
      <td>2010</td>
      <td>2010-12-13</td>
      <td>PMC</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7168442" target="_blank">PMC7168442</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/19714577.0" target="_blank">19714577.0</a></td>
      <td><a href="https://doi.org/10.1002/med.20176" target="_blank">10.1002/med.20176</a></td>
      <td>ycc3csyh</td>
      <td>0.300002</td>
      <td></td>
      <td></td>
    </tr>
  </tbody>
</table>
</body>
</html>
